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P-3 is a member of the adaptor protein (AP)
complex family that regulates the vesicular trans-
port of cargo proteins in the secretory and
endocytic pathways. There are two isoforms of AP-3: the
ubiquitously expressed AP-3A and the neuron-speciﬁc
AP-3B. Although the physiological role of AP-3A has re-
cently been elucidated, that of AP-3B remains unsolved.
To address this question, we generated mice lacking 
 
 
 
3B,
a subunit of AP-3B. 
 
 
 
3B
 
 
 
/
 
 
 
 mice suffered from spontaneous
epileptic seizures. Morphological abnormalities were
A
 
observed at synapses in these mice. Biochemical studies
demonstrated the impairment of 
 
 
 
-aminobutyric acid
(GABA) release because of, at least in part, the reduction
of vesicular GABA transporter in 
 
 
 
3B
 
 
 
/
 
 
 
 mice. This facil-
itated the induction of long-term potentiation in the hippo-
campus and the abnormal propagation of neuronal excit-
ability via the temporoammonic pathway. Thus, AP-3B
plays a critical role in the normal formation and function
of a subset of synaptic vesicles. This work adds a new
aspect to the pathogenesis of epilepsy.
 
Introduction
 
Adaptor protein (AP) complexes, along with clathrin, regulate
the formation of clathrin-coated vesicles and the signal-mediated
sorting of integral membrane proteins in the late secretory and
endocytic pathways (Nakatsu and Ohno, 2003). AP complexes
consist of four subunits, including two large chains (
 
 
 
, 
 
 
 
, 
 
 
 
 or 
 
 
 
and 
 
 
 
), one medium chain (
 
 
 
), and one small chain (
 
 
 
) (Hirst
and Robinson, 1998; Bonifacino and Dell’Angelica, 1999). We
have demonstrated previously that 
 
 
 
 subunits directly recognize
tyrosine-based sorting motifs, one of the most commonly used
sorting signals within the cytoplasmic tail of cargo membrane
proteins, which enables the signal-mediated vesicular transport
(Ohno et al., 1995; Kirchhausen et al., 1997). Six distinct 
 
 
 
subunits exist in mammalian genome (Boehm and Bonifacino,
2001). Among them are the two isoforms of 
 
 
 
3, 
 
 
 
3A, and 
 
 
 
3B.
 
 
 
3A is ubiquitously expressed and forms the AP-3A complex in
conjunction with, 
 
  
 
3A, and 
 
 
 
3 subunits. AP-3A plays an im-
portant role in the transport of membrane proteins to, as well as
the biogenesis of, lysosomes and lysosome-related organelles
(Odorizzi et al., 1998). In contrast, 
 
 
 
3B is exclusively ex-
pressed in neurons and forms the neuron-specific AP-3B com-
plex along with 
 
 
 
3B, another neuron-specific subunit (Pevsner et
al., 1994; Newman et al., 1995). The other two subunits of
AP-3B, 
 
 
 
, and 
 
 
 
3, are shared by the two AP-3 isoforms.
Mutations in the 
 
 
 
3A subunit of ubiquitous AP-3A have
been identified in patients suffering from the Hermansky-
Pudlak syndrome (HPS), in which the function and/or biogenesis
of lysosomes and lysosome-related organelles such as melano-
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somes and platelet dense granules are impaired (Dell’Angelica
et al., 1999; Swank et al., 2000). As a result, the HPS patients
suffer from such symptoms as abnormal secretion of lysosomal
enzymes, pigmentation defect, and prolonged bleeding time.
 
Pearl
 
 mice, one of the HPS model mutants, also bear a muta-
tion in the 
 
 
 
3A gene and share the same phenotypes with HPS
patients (Feng et al., 1999). Another HPS model, 
 
mocha
 
 mice,
has mutations in the common 
 
 
 
 subunit (Kantheti et al., 1998).
As a result, in addition to the phenotypes seen in 
 
pearl
 
 mice and
HPS patients, 
 
mocha
 
 mice suffer from neurological disorders,
such as abnormal electrocorticogram, the recording of electrical
activity from cerebral cortex, and inner ear disorders (deafness
and balance problem; Rolfsen and Erway, 1984; Noebels and
Sidman, 1989; Kantheti et al., 1998). It is possible that these
dysfunctions are due to the absence of AP-3B in 
 
mocha
 
 mice,
although little is known about the role of AP-3B in vivo.
To investigate the physiological role of AP-3B, we gener-
ated 
 
 
 
3B-deficient mice using the gene targeting technique.
Morphological analyses indicated that AP-3B is involved in the
biogenesis of synaptic vesicles in vivo. Biochemical and elec-
trophysiological studies corroborated the dysfunction of 
 
 
 
-ami-
nobutyric acid (GABA) ergic synaptic transmission in 
 
 
 
3B
 
 
 
/
 
 
 
mice. Consequently, the 
 
 
 
3B
 
 
 
/
 
 
 
 mice suffered from spontane-
ous recurrent epileptic seizures. These findings suggest that
AP-3B is responsible for efficient synaptic transmission, par-
ticularly the inhibitory one, by regulating the formation and
function of a subset of synaptic vesicles.
 
Results
 
Generation of 
 
 
 
3B-deficient mice
 
To disrupt the 
 
 
 
3B locus in E14.1 embryonic stem (ES) cells,
the downstream of the start codon of 
 
 
 
3B exon 2 was replaced
with EGFP cDNA and neomycin (Neo) resistance gene flanked
with loxP sequences by homologous recombination (Fig. 1 A).
ES cell lines with the mutant allele were injected into blasto-
cysts from C57BL/6 mice to obtain chimeric offspring. After
crossing these chimeras with C57BL/6 mice, heterozygous ani-
mals were identified by Southern blotting of tail DNA using 5
 
 
 
and 3
 
 
 
 probes (Fig. 1, B and C). It has been reported that Neo
gene inserted into the genome may perturb the expression of
adjacent genes in several knockout mice (Olson et al., 1996).
To avoid this possibility, we removed Neo gene by crossing the
 
 
 
3B
 
 
 
/
 
 
 
 mice with Cre-transgenic mice (Sakai and Miyazaki,
1997) to establish 
 
 
 
3B
 
 
 
/
 
 
 
 
 
Neo mice (Fig. 1 D). We further
backcrossed 
 
 
 
3B
 
 
 
/
 
 
 
 
 
Neo mice with C57BL/6 mice to avoid a
possible variation of the phenotype(s) with the mixed genotype
of C57BL/6 
 
 
 
 129.
The disruption of the 
 
 
 
3B gene in 
 
 
 
3B
 
 
 
/
 
 
 
 
 
Neo mice
was verified by RT-PCR (Fig. 1 E). The expression of 
 
 
 
3B
transcripts was detected in the brain and the spinal cord
of wild-type and 
 
 
 
3B
 
 
 
/
 
 
 
 
 
Neo mice, but not in those of
 
 
 
3B
 
 
 
/
 
 
 
 
 
Neo mice. Alternatively, EGFP gene was expressed
only in 
 
 
 
3B
 
 
 
/
 
 
 
 
 
Neo and 
 
 
 
3B
 
 
 
/
 
 
 
 
 
Neo mice. We also detected
the expression of EGFP immunohistochemically in neurons
Figure 1. Targeted disruption of  3B gene by homologous
recombination. (A) Structure of mouse  3B gene including
the exon encoding ATG start codon (wild type); the tar-
geting vector containing 5  (3.0 kb) and 3  (1.5 kb)
homologous regions, the EGFP gene, the Neo gene
flanked with two loxP sites, and the herpes simplex virus-
thymidine kinase (HSV-tk) gene for positive and negative
selections (targeting vector); the resultant mutant allele
generated by homologous recombination (mutant); and
the mutant allele lacking the Neo gene after crossing with
Cre-transgenic mice ( Neo). The following restriction
enzyme sites are indicated: H, HindIII; Sc, SacI; Se, SpeI;
and Sh, SphI. An additional HindIII site, shown by (H)*,
exists only in the genome from C57BL/6 mice and not in
that from 129 mice. (B–D) Southern blotting using 5 
(probe L) and 3  (probe S) probes as depicted in A.
Digestion of genome DNA with HindIII and SpeI yielded
a 3.6-kb wild-type band and a 2.5-kb band generated by
homologous recombination using probe S (B). Similarly,
digestion of genome DNA with SacI and SphI yielded a
6.4-kb wild-type band and a 5.5-kb band generated by
homologous recombination using probe L (C). The mutant
allele digested with HindIII and SacI became 1.2 kb
shorter (from 6.5 to 5.3 kb) using probe L after deletion
of the Neo gene by crossing with Cre-transgenic mice
(D, compare first and second lanes). Data shown in D
were obtained using mice with C57BL/6 background.
Note that the additional HindIII site ((H)*, A) in C57BL/6
genome gave a 2-kb band corresponding the C57BL/6
wild-type allele (third lane). (E) RT-PCR analysis using total
RNA from brain (left) or spinal cord (right) as a template for
PCR. (F) Whole brain lysates from wild-type,  3B
 /  Neo
and  3B
 /  Neo mice were subjected to immunoblotting
with anti- 3 (top left) and anti- 3B (top right) antibodies.
After stripping off the antibodies, both membranes were
reblotted with anti–  adaptin (bottom) as an internal con-
trol for the amount of protein in each lane.SYNAPTIC DISORDER IN MICE LACKING  3B • NAKATSU ET AL. 295
throughout the brain, with stronger signals particularly in
the hippocampus and the dentate gyrus (unpublished data),
where  3B, another neuron-specific subunit of AP-3B, was
also abundantly expressed (Newman et al., 1995). Immuno-
blot analysis of  3A/B using anti- 3A/B antibody revealed
that the amount of  3 proteins in whole brain lysates from
 3B
 /  Neo mice was decreased to approximately half that
from wild-type mice, indicating that there is no compensa-
tory mechanism for  3B deficiency by increasing the amount
of  3A protein in  3B
 /  Neo mice (Fig. 1 F). Immunoblot
analysis also revealed that the expression of  3B, another
neuron-specific subunit of AP-3B, was barely detectable in
 3B
 /  Neo mice (Fig. 1 F), consistent with previous stud-
ies (Kantheti et al., 1998; Dell’Angelica et al., 1999) showing
that other subunits of AP complexes become unstable and are
rapidly degraded in the absence of one of their subunits, and
indicating that  3B can assemble with only  3B and not
 3A to constitute the neuron-specific AP-3B. Thus, the dis-
ruption of  3B resulted in the disappearance of AP-3B in
 3B
 /  Neo mice.
Seizure susceptibility of  3B
 /  Neo mice
The frequency of birth of  3B
 /  Neo mice was in accor-
dance with Mendelian expectations. The mice were fertile
and survived for at least more than one year. Although the
 3B
 /  Neo mice appeared normal, some adult mice exhib-
ited spontaneous epileptic seizures upon presentation of such
stimuli as positional change (Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200405032/DC1). More than
half of the mice suffered from seizures at the age of 15 wk or
over. In addition, the electrocorticogram revealed that all of the
 3B
 /  Neo mice tested showed an abnormal epileptic pat-
tern, namely, interictal spikes, which was never observed in
wild-type mice (Fig. 2 A). These observations prompted us to
test the seizure susceptibility of  3B
 /  Neo mice.
Intravenous infusion of pentylenetetrazole (PTZ), a
GABAA receptor antagonist, elicits a series of stereotyped re-
sponses beginning with a period of intermittent twitches of the
head and body, leading to tonic–clonic activity, followed by a
phase of tonic extension and death (Tecott et al., 1995). PTZ
was infused into the tail vein of wild-type and  3B
 /  Neo
mice, and the susceptibility to PTZ was analyzed. Both 4- and
8-wk-old   3B
 /  Neo mice required only 40–70% of the
amount of PTZ required by wild-type mice to reach the same
stages of seizure (Fig. 2 B).
We further examined the seizure susceptibility of
 3B
 /  Neo mice by electrical kindling, an established
model for experimental seizure (Goddard, 1967). General-
ized seizure (class 5) was observed in wild-type mice after
10–12 stimulations (Fig. 2 C). Notably, all the  3B
 /  Neo
mice tested reached class 5 within the first two stimulations.
Consistently, the afterdischarge, electrical activity recorded
after stimulation, evoked by the first kindling stimulation
lasted much longer in  3B
 /  Neo mice than in wild-type
mice (Fig. 2 D; average of the duration of afterdischarge:
7.0   1.3 s in wild-type mice (n   4) vs. 14.1   4.1 s in
 3B
 /  Neo mice (n   4), P   0.05, t test). Furthermore,
the seizure phenotype of  3B
 /  Neo mice subjected to
kindling stimulation was different from that of wild-type
mice, but identical to the spontaneous seizure displayed by
 3B
 /  Neo mice (unpublished data). Therefore, it is likely
that the generalized seizure in  3B
 /  Neo mice evoked by
kindling stimulation is due to intrinsic epileptogenesis rather
than acquired one by the kindling. Together, these results
demonstrate that  3B
 /  Neo mice have higher seizure sus-
ceptibility than wild-type mice.
Figure 2. Increased seizure susceptibility of  3B
 /  Neo mice. (A) Rep-
resentative electrocorticogram recorded from  3B
 /  Neo mice (n   7)
during the interictal period. Interictal spikes are underlined. (B) Seizure
was induced by intravenous administration of PTZ, a GABAA receptor
antagonist, in 4-wk-old (left) and 8-wk-old (right) wild-type (closed circle; 4
wk old, n   6; 8 wk old, n   5) and  3B
 /  Neo (closed square; 4 wk
old, n   4; 8 wk old, n   5) mice. Seizure stages were judged as de-
scribed previously (see Materials and methods). Results are expressed as
means   SEM (* indicates P   0.05; ** indicates P   0.01). (C) Seizure
development by amygdala kindling. Kindling experiments were performed
as described previously (see Materials and methods), and the develop-
ment of seizure classes in individual animals is plotted against the number
of kindling stimulations. (D) Typical afterdischarge of wild-type (top) or
 3B
 /  Neo mice (bottom) induced by the first kindling stimulation.JCB • VOLUME 167 • NUMBER 2 • 2004 296
Morphological abnormalities in excitatory 
and inhibitory presynaptic terminals of 
 3B
 /  Neo mice
There was no difference in brain weight between wild-type
and  3B
 /  Neo mice at any of the postnatal developmental
phases. Conventional histological examination including Nissl
as well as hematoxylin and eosin staining revealed no abnor-
mality in the overall structure of the brain from  3B
 /  Neo
mice (unpublished data). Immunohistochemistry showed no as-
trogliosis in the hippocampus, indicative of neuronal degenera-
tion, suggesting that apparent neuronal cell death does not oc-
cur in  3B
 /  Neo mice (unpublished data).
We next performed ultrastructural examination of the
hippocampus. The number of synaptic vesicles per unit area
was decreased in  3B
 /  Neo mice. The density of synaptic
vesicles in excitatory terminals was lower in  3B
 /  Neo
mice than in wild-type mice at the age of 4–16 wk (Fig. 3, A,
B, and E). The density of synaptic vesicles in inhibitory termi-
nals was also lower in  3B
 /  Neo mice than in wild-type
mice at the age of 2, 6, and 8 wk (Fig. 3, C, D, and F). In addi-
tion, the diameter of the synaptic vesicles in inhibitory synaptic
terminals in  3B
 /  Neo mice was evidently smaller than that
in wild-type mice (Fig. 3, G and H). Thus, these results indicate
that AP-3B is involved in the biogenesis of synaptic vesicles in
hippocampus in vivo.
Impairment of GABA release due to 
reduction of VGAT in  3B
 /  Neo mice
That  3B
 /  Neo mice exhibited morphological abnormali-
ties in synapses led us to ask whether the release of neurotrans-
mitters was impaired in these mice. To this end, the release of
glutamate and GABA in the hippocampal minislice was mea-
sured. The amounts of basal release were similar between
 3B
 /  Neo mice and wild-type mice at all the ages tested
(Fig. 4, A and B). However, the K
 -evoked release of GABA,
but not of glutamate, was impaired in  3B
 /  Neo mice at 8
wk old or over (Fig. 4, A and B). As the contents of these neu-
rotransmitters in the hippocampus were equivalent between
wild-type and  3B
 /  Neo mice (unpublished data), the dif-
ference in GABA release could not be attributed to the changes
in the metabolism of GABA itself. Therefore, we postulated
that the accumulation of GABA in synaptic vesicles may be
impaired, and examined the amounts of vesicular GABA trans-
porter (VGAT) and VGLUT, transporters responsible for the
uptake of GABA and glutamate into the synaptic vesicles, re-
spectively (McIntire et al., 1997; Reimer et al., 1998; Gasnier,
2000; Fremeau et al., 2001). The amount of VGAT protein was
decreased significantly in synaptosomal lysates from the hip-
pocampus of  3B
 /  Neo mice (Fig. 4, C and D) despite the
fact that the amounts of VGLUT1 and VGLUT2, and other
synaptic vesicle proteins such as synaptophysin, synaptotag-
min, VAMP2, rabphilin-3A, and Rab3A (Fig. 4 C) were un-
changed. This was not due to the decrease or loss of the inhibi-
tory neurons themselves, because there was no difference in the
number of neurons immunoreactive for GAD67, a marker for
inhibitory neurons (unpublished data). These results suggest
that the impairment of GABA release in  3B
 /  Neo mice is
attributable, at least in part, to the decrease in the amount of
VGAT protein in the hippocampus.
As we mentioned earlier,  3B is expressed in neurons
throughout the brain despite strongest in hippocampus. To test
whether the reduction of VGAT proteins is limited to the hip-
pocampus, we performed biochemical quantification of the
Figure 3. Ultrastructural analysis of synaptic terminals. (A–D) Electron
micrographs of asymmetric (excitatory) terminals (A and B) and symmetric
(inhibitory) terminals attaching to perikarya of CA1 pyramidal neurons
(C and D) in the CA1 in wild-type (A and C) and  3B
 /  Neo (B and D)
mice at the age of 8 wk. Bar, 200 nm. (E–H) Developmental changes in
the number of synaptic vesicles per unit area (E and F) and the diameter of
synaptic vesicles (G and H) of excitatory (E and G) and inhibitory terminals
(F and H) in  3B
 /  Neo mice (open square) and wild-type mice (solid
square). 30–50 areas (E and F) and  500 synaptic vesicles (G and H)
from both genotypes (n   3 each) were counted, respectively. Values are
expressed as means   SEM Student’s or Welch’s t test was used to deter-
mine the differences between  3B
 /  Neo and wild-type mice (* indi-
cates P   0.05; ** indicates P   0.01).SYNAPTIC DISORDER IN MICE LACKING  3B • NAKATSU ET AL. 297
VGAT protein level in the whole brain. In contrast to the hip-
pocampus, the amount of VGAT, along with other synaptic
vesicle proteins, in the crude synaptic vesicle fraction LP2 as
well as in the total lysate from  3B
 /  Neo whole brain was
equivalent to those from wild-type whole brain (Fig. 4 C), sug-
gesting that AP-3B is involved in the biogenesis of a subset of
synaptic vesicles in vivo.
We next examined whether  3B deficiency affected the
localization of the synaptic vesicle proteins including VGAT.
Immunohistochemical staining revealed that the distribution of
VGAT in the hippocampus from  3B
 /  Neo mice is compa-
rable to that from wild-type mice (Fig. S1, A and I, available
at http://www.jcb.org/cgi/content/full/jcb.200405032/DC1). In
cultured hippocampal neurons, VGAT was observed only in
axon, where it colocalized with synaptophysin in  3B-defi-
cient as well as wild-type neurons at 3 d in vitro (Fig. S1, B and
J), suggesting that VGAT was targeted to the axon properly in
 3B-deficient neuron. At 14 d in vitro, VGAT was colocalized
with both synaptophysin (Fig. S1, C, D, K, and L) and synap-
totagmin (Fig. S1, G and O) at synaptic boutons in wild-type
and  3B
 /  Neo neurons. VGLUT1 was also colocalized with
both synaptophysin (Fig. S1, E, F, M, and N) and synaptotag-
min (not depicted) in neurons from both genotypes. Localiza-
tion of VAMP2 was also normal in  3B
 /  Neo neuron (Fig.
S1, H and P). These results indicate that there is no obvious ab-
normality in the localization of synaptic vesicle proteins in-
cluding VGAT in  3B
 /  Neo neurons.
Synaptic potentiation is enhanced in 
 3B
 /  Neo mice through reduced 
GABAergic synaptic inhibition
It is well established that the threshold for the induction of
long-term potentiation (LTP) of excitatory synaptic transmis-
sion in the hippocampal CA1 region is regulated by GABAA
receptor-mediated inhibitory synaptic inputs that are activated
by afferent fiber stimulation for LTP induction (Wigstrom and
Gustafsson, 1983): disinhibition by the blockade of GABAA re-
ceptor facilitates LTP induction. To test whether GABAergic
synaptic inhibition is impaired in  3B
 /  Neo mice, we exam-
ined the effect of picrotoxin (PTX; 100  M), a GABAA recep-
tor antagonist, on LTP induction. LTP induced by standard
conditioning (100 Hz for 1 s) in  3B
 /  Neo mice was intact
either in the presence (P   0.05; Fig. 5 A) or in the absence
(P   0.05; Fig. 5 B) of PTX. However, when weak condition-
ing (100 Hz for 200 ms) was applied in the absence of PTX
(Fig. 5 D), LTP was not induced in wild-type mice (99.3  
1.4% of baseline), whereas stable potentiation was induced in
 3B
 /  Neo mice (117.7   1.7% of baseline; P   0.05). This
difference disappeared when PTX was present (P   0.05; Fig.
5 C), indicating that the phenotype observed in Fig. 5 D was
dependent on GABAA receptor-mediated synaptic transmis-
sion. Thus, it is conceivable that when a weaker tetanus is used,
the influence of inhibition is relatively stronger and LTP induc-
tion is suppressed in wild-type mice, whereas LTP is induced
in  3B
 /  Neo mice because the inhibition is weaker. These
results suggest impaired GABAergic synaptic transmission in
 3B
 /  Neo mice, and are consistent with the reduced GABA
release from presynaptic terminals in  3B
 /  Neo mice.
Abnormal propagation of neuronal 
excitability to CA1 pyramidal cell via TA 
pathway in  3B
 /  Neo mice
To investigate the influence of the impairment in GABAergic
synapses on hippocampal transmission in  3B
 /  Neo mice,
we analyzed the propagation of neuronal excitability from the
entorhinal cortex (EC) to the hippocampus using optical re-
cording. It is well established that superficial layers of the EC
project to the dentate gyrus granule cells via the perforant path-
way, and to CA1 pyramidal cells via the temporoammonic
(TA) pathway (Heinemann et al., 2000). The TA pathway is
composed of both direct excitatory and indirect inhibitory
GABAergic interneuron-associated projections (Fig. 6 A; Hei-
Figure 4. Impairment of GABA release due
to reduction of VGAT in  3B
 /  Neo mice.
(A and B) Measurement of glutamate (A) and
GABA (B) release was performed as described
in Materials and methods. Basal (circles) and
K
 -evoked (squares) release of wild-type
(closed symbols) and  3B
 /  Neo mice
(open symbols) is shown (n   3 each). Results
are expressed as means   SEM (* indicates
P   0.05; ** indicates P   0.01). (C) Western
blotting of VGAT, VGLUT1, VGLUT2, synapto-
physin, synaptotagmin, rabphilin-3A, Rab3A,
and VAMP2 in total (lanes 1, 2, 5, and 6) and
synaptosomal (lanes 3 and 4) or LP2 (lanes 7
and 8) lysates from hippocampus (left) and
whole brain (right) of wild-type (lanes 1, 3, 5,
and 7) and  3B
 /  Neo (lanes 2, 4, 6, and
8) mice. Shown are the representatives of four
independent experiments. (D) Quantitative
analysis of the amount of VGAT protein in total
(left) and synaptosomal (right) hippocampal ly-
sates of wild-type and  3B
 /  Neo mice (n  
4 each) as shown in C. Results are expressed
as means   SD. (* indicates P   0.05). AU,
arbitrary unit.JCB • VOLUME 167 • NUMBER 2 • 2004 298
nemann et al., 2000; Remondes and Schuman, 2002). In 4-wk-
old wild-type and  3B
 /  Neo mice as well as in 8-wk-old
wild-type mice, the neuronal excitability evoked by electrical
stimulation of layers II, III, and IV in EC propagated to the
dentate gyrus via the perforant pathway, but not to the CA1 py-
ramidal cells via the TA pathway (Fig. 6, B and C). In contrast,
the neuronal excitability propagated from EC to CA1 pyra-
midal cells in addition to the dentate gyrus in 8-wk-old
 3B
 /  Neo mice (Fig. 6, B and C). Consistent with our pre-
vious observation (Okada et al., 2004), the propagation of neuronal
excitability via both perforant and TA pathways was observed in
the presence of bicuculline, a GABAA receptor antagonist, in all
cases (unpublished data). These results suggest that the abnormal
excitability observed in  3B
 /  Neo mice is due to the impair-
ment in GABAergic inhibition in the TA pathway.
Discussion
There are two distinct pathways for synaptic vesicle formation:
endocytosis or recycling from the plasma membrane and bud-
ding from the endosomal membrane (Hannah et al., 1999; Mur-
thy and De Camilli, 2003). Although the AP-2–dependent re-
cycling pathway is believed to be the major pathway for the
generation of synaptic vesicles (Murthy and De Camilli, 2003),
the importance of the endosomal pathway for the biogenesis of
synaptic vesicles has been unclear. Although we and others
have shown the implication of AP-3B in the biogenesis of syn-
aptic vesicles from endosomes in vitro (Faundez et al., 1998;
Blumstein et al., 2001), its physiological role has remained un-
certain. Here, we demonstrated that hippocampal inhibitory
synaptic vesicles in  3B-deficient mice show defects in both
morphology and function, indicating that AP-3B plays an es-
sential role in normal synaptic function in vivo by regulating
the biogenesis of at least a subset of synaptic vesicles. Thus,
this work is the first to demonstrate that, in addition to AP-2–
dependent recycling pathway, the AP-3B–dependent synaptic
vesicle formation is also of physiological importance in the
central nervous system.
 3B
 /  Neo mice were observed to suffer from sponta-
neous recurrent epileptic seizures. They were also more sus-
ceptible to drug-induced seizures than their wild-type counter-
part. The kindling procedure revealed that  3B
 /  Neo mice
rapidly reached class 5, or generalized seizure. Judging from
the observations of the seizure phenotype, however, we sur-
mise that the generalized seizure in  3B
 /  Neo mice evoked
by kindling stimulation is due to intrinsic epileptogenesis
rather than induction by the kindling. It is considered that the
suppression by inhibitory neurons of the propagation of kin-
dling–stimulation-induced hyperexcitability prevents the de-
velopment of behavioral seizures in wild-type mice at the
early stages of kindling (Sato et al., 1990). Therefore, the gen-
eralized seizure in  3B
 /  Neo mice induced at the early
stages of kindling further suggests a disorder in the inhibitory
neurons in the mice.
AP-3A deficiency in mammals, such as HPS patients and
pearl mice, was reported to result in the dysfunction of lyso-
somes and lysosome-related organelles (Dell’Angelica et al.,
1999; Swank et al., 2000). In contrast to AP-3A, however, the
function of AP-3B has remained unknown. Mocha mice lack-
ing both AP-3A and AP-3B show neurological phenotypes in-
cluding abnormal electrocorticogram and inner ear disorders
such as deafness and balance problem, in addition to the pheno-
type seen in AP-3A deficiency (Noebels and Sidman, 1989;
Kantheti et al., 1998). Therefore, the neurological disorder
observed in mocha mice has been predicted to be due to
the AP-3B deficiency. Contrary to the prediction, however,
 3B
 /  Neo mice exhibited neither deafness nor balance
problem. The inner ear disorder has been attributed to an insuf-
ficiency of heavy metals such as zinc and/or manganese (Rolf-
sen and Erway, 1984). Kantheti et al. (1998) reported the lack
of zinc as well as ZnT-3, a zinc transporter localized in synap-
tic vesicles, in the brain of mocha mice. By contrast, we ob-
served neither any apparent differences in zinc staining nor
the immunolocalization of ZnT-3 in the hippocampus of
 3B
 /  Neo mice as well as pearl mice, consistent with the
lack of inner ear symptoms in these mice (unpublished data).
These observations suggest that the inner ear phenotype as well
as the mislocalization of ZnT-3 only appears when both AP-3A
and AP-3B are deficient in mocha mice.
Functional as well as ultrastructural analyses corrobo-
rate the impaired inhibitory synaptic transmission in the ab-
sence of  3B. The K
 -evoked release of GABA was de-
creased significantly in  3B
 /  Neo mice compared with
wild-type mice, whereas that of glutamate was not af-
fected. Electrophysiological experiments demonstrated that,
Figure 5. Enhanced synaptic potentiation through reduced GABAergic
synaptic inhibition in  3B
 /  Neo mice. (A–D) The average time course of
the slope of synaptic responses in  3B
 /  Neo mice and their littermate
wild-type mice. Initial EPSP slopes were normalized in each experiment to
the average slope value of the baseline ( 30–0 min). The potentiation ratio
was calculated by dividing the average slope value from 50 to 60 min by
that of the baseline. Afferent fibers were tetanized at time 0 at: (A) 100 Hz
for 1 s in the presence of PTX in wild-type (open circles; n   18) and
 3B
 /  Neo (closed circles; n   19) mice; (B) 100 Hz for 1 s in the
absence of PTX in wild-type (open circles; n    16) and  3B
 /  Neo
(closed circles; n   13) mice; (C) 100 Hz for 200 ms in the presence of
PTX in wild-type (open circles; n   10) and  3B
 /  Neo (closed circles;
n   10) mice; and (D) 100 Hz for 200 ms in the absence of PTX in wild-type
(open circles; n   14) and  3B
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in  3B
 /  Neo mice, LTP was induced under the condition
that synaptic potentiation was not induced because of the
GABAergic synaptic inhibition in wild-type mice. Further-
more, optical recording experiments demonstrated that the
neuronal excitability in EC propagated to the CA1 region in
the  3B-deficient condition (8-wk-old  3B
 /  Neo mice),
which was not observed in the normal condition. The TA
pathway can enhance via direct excitatory projection, or sup-
press via indirect GABAergic interneuron-associated projec-
tion, the excitability of CA1 pyramidal cells (Heinemann et
al., 2000; Remondes and Schuman, 2002). Together, the re-
sults suggest the impairment of GABAergic synaptic inhibi-
tion and are consistent with the impairment of GABA release
in  3B
 /  Neo mice.
Considering that AP-3B is likely expressed in virtually
all neurons, the apparent difference in phenotype between exci-
tatory and inhibitory neurons is not fully understood. Similar
phenotypic differences between excitatory and inhibitory neu-
rons were observed in several mice deficient in synaptic vesicle
proteins (Augustin et al., 1999; Terada et al., 1999; Schoch et
al., 2002). Excitatory and inhibitory neurons may exhibit dif-
ferent dependences on these molecules as well as AP-3B to ex-
ert their functions. It is also possible that an inhibitory-syn-
apse–specific cargo protein of AP-3B may be responsible for
the difference. We surmise that VGAT is an obvious cargo can-
didate. The amount of VGAT was decreased in the hippocam-
pus of  3B
 /  Neo mice. It has been shown that unc-47, a
VGAT mutant of C. elegans, displays an impairment in
Figure 6. Abnormal propagation of neuronal excitability via TA
pathway in  3B
 /  Neo mice. (A) Schematic of neuronal circuits in
EC–hippocampus pathway. Black arrows indicate the trisynaptic
pathway that includes the perforant, mossy fiber and Schaffer collateral
pathways. Red and blue arrows indicate excitatory and inhibitory
projections in the TA pathway, respectively. (B) Change in fluores-
cence signal associated with propagation of neuronal excitabilities in
EC–hippocampal formation of 4-wk-old (4w) and 8-wk-old (8w) wild-
type ( / ) and  3B
 /  Neo ( / ) mice after the electrical stimula-
tion of EC layers II, III, and IV. Pseudo colors indicate  10
3-fold
(change in fluorescence intensity/initial fluorescence intensity    F/F)
elevation in the amplitude of the fluorescence signal. (C) Mean values
of optical signals in dentate gyrus and CA1 regions after the electrical
stimulation of EC layers II, III, and IV in 4-wk-old wild-type (closed circle,
n   5), 4-wk-old  3B
 /  Neo (open circle, n   5), 8-wk-old wild-
type (closed square, n     5), and 8-wk-old  3B
 /  Neo (open
square, n   4) mice. Ordinates indicate the change in fluorescence
intensity/initial fluorescence intensity ( F/F), and abscissas indicate
time after stimulation (msec).JCB • VOLUME 167 • NUMBER 2 • 2004 300
GABAergic neurotransmission (McIntire et al., 1997). There-
fore, it is conceivable that the impairment of GABAergic syn-
aptic function in  3B
 /  Neo mice is, at least in part, due to
the reduction of the hippocampal VGAT proteins. Notably, we
have identified a potential di-leucine signal, one of the well-
characterized sorting signals recognized by AP complexes
(Bonifacino and Traub, 2003), in the cytoplasmic tail of VGAT
(unpublished data). Thus, AP-3B may play a role in the inclu-
sion of VGAT into synaptic vesicles. However, no reduction of
VGAT was detected in the whole brain of  3B
 /  Neo mice.
One of the possible explanations is that the reduction was ap-
parent in the  3B
 /  Neo hippocampus, where the expression
level of the  3B is among the highest and more neurons may
depend on  3B for the targeting of VGAT to synaptic vesicles.
Further studies are conducted to address this issue.
In conclusion, the present work has demonstrated the crit-
ical role of AP-3B in functional synaptic transmission, particu-
larly the inhibitory one.  3B deficiency caused an impairment
of GABA release possibly because of the reduction of VGAT,
which is reflected by the decreased threshold of LTP induction
and the abnormal propagation of neuronal excitability in the
hippocampus. As a result,  3B-deficient mice suffered from
recurrent epileptic seizure.  3B
 /  Neo mice may serve as a
novel animal model of epilepsy, one of the most common neu-
rological disorders, to benefit epileptic patients in the future.
Materials and methods
Animals
All animal experiments were performed in accordance with the guidelines
for the care and use of laboratory animals in RIKEN, Kanazawa Univer-
sity, Hirosaki University, Kobe University, Chiba University, Hokkaido Uni-
versity, and University of Tokyo.
Generation of  3B-deficient mice
A genomic DNA clone containing the  3B gene was isolated from a
mouse 129SV/J genomic library (Stratagene). The targeting vector con-
sisted of a 3-kb EcoRI genomic fragment, EGFP cDNA (CLONTECH Labo-
ratories, Inc.), the Neo gene flanked with two loxP sites (H. Gu, Columbia
University, New York, NY; Nishimura et al., 2002) at both ends, a 1.5-
kb SalI–BamHI genomic fragment, and the HSV-tk gene in pBluescript II
SK( ) (Stratagene), as depicted in Fig. 1. EGFP cDNA was placed in
frame immediately after the start codon of the  3B gene so that EGFP
was transcribed under the control of  3B promoter activity. The targeting
vector was transfected into ES cells by electroporation. Homologous re-
combination was confirmed by Southern blotting using both probes S (a
PCR product) and L (an EcoRI–Ssp I 0.5-kb fragment).  3B
 /  mice were
generated essentially as described previously (Ohno et al., 1993). We
obtained   3B
 /  mice lacking the Neo gene ( 3B
 /  Neo mice) by
crossing them with Cre-transgenic mice (Sakai and Miyazaki, 1997). De-
letion of the Neo gene was confirmed by Southern blotting using both
probe L (Fig. 1 A) and Neo probe (not depicted). We further backcrossed
the  3B
 /  Neo mice with C57BL/6 mice to at least seven generations
to establish  3B
 /  Neo mice with the C57BL/6 background. RT-PCR
was performed using sense (5 -atgctggacaatgggttcccc-3 ) and antisense
(5 -aattgtagggttctcatcggg-3 ) primers for  3B, and sense (5 -caccggc-
ctctccaccatg-3 ) and antisense (5 -gtgttctgctggtagtggtcg-3 ) primers for
EGFP. All experiments were conducted using littermate or age-matched
C57BL/6 mice as control.
Immunoblotting
Whole brains or hippocampi from mice with both genotypes were homog-
enized in lysis buffer containing 320 mM sucrose and 10 mM Hepes, pH
7.4, with protease inhibitors (Roche Molecular Biochemicals). Synaptoso-
mal and LP2 fraction was prepared as described previously (Huttner et al.,
1983). The lysates were subjected to SDS-PAGE and immunoblotting us-
ing the following antibodies: anti–  adaptin (AP.6; American Type Culture
Collection), anti-synaptotagmin and anti-VAMP2 (M. Takahashi, Kitazato
University, Sagamihara, Japan), anti-synaptophysin (SY38; PROGEN),
anti–rabphilin-3A and  3B (BD Transduction Laboratory), anti- 3 (J.S.
Bonifacino, National Institutes of Health, Bethesda, MD), anti-Rab3A (Y.
Takai, Osaka University, Suita, Japan), anti-GAPDH (CHEMICON Interna-
tional, Inc.), anti-VGLUT1 and anti-VGLUT2 (R.H. Edwards, University of
California San Francisco, San Francisco, CA), anti-ZnT3 antibody (T.
Palmiter, University of Washington, Seattle, WA), and anti-VGAT anti-
body (Miyazaki et al., 2003). Western blots were visualized with an ECL
system (Super Signal; Pierce Chemical Co.). Chemiluminescence signals
were detected by LAS-1000 plus (Fuji Photo Film) and quantified using Im-
age Gause Software (Fuji Photo Film).
Electrocorticogram
Mice were anesthetized with pentobarbital (40 mg/kg, i.p.). Bipolar silver
ball electrodes (diameter, 1.0 mm; distance, 3.5 mm) were stereotaxically
implanted onto the epidural surface of the left primary motor and left pri-
mary somatosensory cortices according to the stereotaxic coordinates of
Franklin and Paxinos (2001): 1.18 mm anterior to the bregma and 1.2
mm lateral to the midline, and 2.06 mm posterior to the bregma and 3.0
mm lateral to the midline, respectively. After convalescence for at least 2
wk, electrocorticogram was recorded with a continuous video-EEG moni-
toring system for freely moving mice.
Pharmacological analysis of seizure susceptibility
The experiment was performed essentially as described previously (Tecott
et al., 1995). In brief, PTZ (Sigma-Aldrich) was infused into the tail vein of
wild-type (4 wk old, n   6; 8 wk old, n   5) or  3B
 /  Neo (4 wk old,
n   4; 8 wk old, n   5) mice at a constant rate (1.5 mg/min) and the time
required by the animals to go through four stages as judged by their be-
havior was measured in a blind fashion. The stages are as follows: stage
I, no movement; stage II, twitches of head and body; stage III, tonic–clonic
convulsion; and stage IV, extension and death.
Electrical kindling
Before the surgical procedures, the mice were anesthetized with pentobar-
bital (40 mg/kg, i.p.). A bipolar stimulation-recording electrode made of
stainless steel was stereotaxically implanted into the left basolateral nu-
cleus of the amygdala according to the stereotaxic coordinates of Franklin
and Paxinos (2001): 1.94 mm posterior from the bregma, 2.9 mm lateral
from the midline and 4.2 mm below the dura mater.
After a recovery period of 10 d, the mice were exposed to kindling
stimulation of the left amygdala once daily, consisting of 2 s, 50 Hz bi-
phasic square pulses at the intensity of the afterdischarge threshold. The
development of behavioral seizures was classified according to the crite-
ria of Racine (1972).
Morphological studies
Mice from both genotypes were anesthetized with pentobarbital sodium
(50 mg/kg) and transcardially perfused with 4% PFA in 0.1 M phosphate
buffer, pH 7.4, at 2, 4, 6, 8, and 16 wk old (n   3, respectively). 4- m-
thick, paraffin-embedded sections were prepared and stained with hema-
toxylin and eosin and by the Klüver-Barrera method.
For immunohistochemistry, 50- m-thick vibratome sections were im-
munostained using the avidin–biotin–peroxidase complex method with a
Vectastain avidin–biotin–peroxidase complex kit (Vector Laboratories).
The sections were incubated with rabbit anti–mouse GAD67 antibody
(1:100; Yamada et al., 2001), rabbit anti-VGAT antibody (1:1,000;
Miyazaki et al., 2003) and rabbit anti-GFAP antibody (1:500; DakoCyto-
mation). The reaction was visualized with 0.02% 3,-3 -DAB tetrachloride
and 0.005% H2O2 in 0.05 M Tris-HCl buffer, pH 7.6, for 10 min at RT.
For EM, the brains were fixed with 2.5% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.4, and 50- m-thick vibratome sections were cut
from the hippocampus. Inhibitory synaptic inputs to the hippocampus are
known to converge onto the perisomatic region as well as the basal and
apical dendrites of pyramidal cells (Freund and Buzsaki, 1996). Virtually
all the synapses on pyramidal cell somata contained pleomorphic vesicles
associated with symmetric membrane differentiations, characteristic of in-
hibitory synapses (Beaulieu and Colonnier, 1985; Freund and Buzsaki,
1996). In addition, nerve terminals immunoreactive for VGAT, a marker
for inhibitory neurons (McIntire et al., 1997; Chaudhry et al., 1998),
were numerous in the perisomatic region of the CA1 pyramidal cells.
Based on these observations, the axon terminals containing pleomorphic
vesicles and making symmetric synaptic contact with the pyramidal cell
somata were considered to be inhibitory GABAergic terminals. Electron
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lacunosum-moleculare (excitatory terminals) and symmetric synaptic termi-
nals that contact with pyramidal cell somata (inhibitory terminals) of the
CA1 were taken from random positions. Morphometric analysis was per-
formed on enlarged prints ( 45,000). The synaptic boutons and vesicles
were digitized using a Macintosh personal computer with a flat head
scanner and an interactive pen display at a final magnification of
90,000. NIH Image 1.62 software was used to calculate the areas of syn-
aptic boutons and the numbers and diameters of the synaptic vesicles. All
morphometric analyses were performed without knowledge of the geno-
type by coding specimens.
Measurement of neurotransmitter level
The determination of neurotransmitter release from the hippocampal minis-
lice was performed according to previous studies (Zhu et al., 2000;
Okada et al., 2003). The levels of glutamate and GABA were determined
by HPLC with fluorescence detection (Zhu et al., 2000; Okada et al.,
2001). The excitation and emission fluorescence wavelengths were 340
and 445 nm, respectively. The mobile phase was 0.1 M phosphate buffer,
pH 6.0, containing 20% methanol and the flow rate was 300 l/min (Zhu et
al., 2000; Okada et al., 2003).
Electrophysiological analysis
Mutant and their littermate wild-type mice (male; 7–14 wk old) were deeply
anesthetized with halothane and decapitated, and then the brains were re-
moved. Hippocampal slices (400  m thick) were cut with a vibratome tissue
slicer and placed in a humidified interface-type holding chamber for at least
1 h. A single slice was then transferred to the recording chamber and sub-
merged in a continuously perfusing medium that had been saturated with
95% O2/5%CO2. The medium contained 119 mM NaCl, 2.5 mM KCl,
1.3 mM MgSO4, 2.5 mM CaCl2, 1.0 mM NaH2PO4, 26.2 mM NaHCO3,
and 11 mM glucose. All experiments were conducted at 25–26 C. Field-
potential recordings were made using a glass electrode (3 M NaCl) placed
in the stratum radiatum of the CA1 region. An amplifier (model Axopatch 1D;
Axon Instruments) was used and the signal was filtered at 1 kHz. Responses
were digitized at 10 kHz, stored in a personal computer and analyzed using
pClamp 8.1 (Axon Instruments). To evoke excitatory synaptic responses, a bi-
polar tungsten stimulating electrode was placed in the stratum radiatum, and
Schaffer collateral/commissural fibers were stimulated at 0.1 Hz. All experi-
ments were performed in a blind fashion. The data are expressed as
means   SEM. The t test was used for determining whether there was a sig-
nificant difference (P   0.05) in the mean between two sets of data.
Optical recording
The procedure for the preparation of brain slices (300  m) including EC
and ventral hippocampus was based on the experimental procedures de-
scribed in a previous work (Okada et al., 2003). After stabilization, 100
mM di-4-ANEPPS (Molecular Probes), dissolved in 2.7% ethanol and
0.13% Cremophor EL, was added to the incubation medium for 30 min to
stain the brain slice. The final concentration of di-4-ANEPPS in the incuba-
tion medium was 100  M.
The MED probe was composed of transparent materials except the
electrodes, thereby allowing the localization of the electrodes in the slice
under a microscope. After staining, each slice was positioned on a MED
probe (MED-P5155; Alpha MED Sciences Co.) such that the array of elec-
trodes was consistent with regard to layers II, III, and IV. The imaging sys-
tem used a high-speed fluorescence CCD camera (MiCAM01; BrainVi-
sion) and a fluorescence microscope (THT-aIII; BrainVision) consisting of
an objective lens (PLANAPO   1; Leica), a projection lens (PLANAPO  
1.6; Leica), a dichroic mirror (575 nm), and absorption (530 nm) and ex-
citation (590 nm) filters (Tominaga et al., 2001; Okada et al., 2004).
During optical recording, the MED probe was superfused with artifi-
cial cerebrospinal fluid (in mM: NaCl 124, KCl 5, MgSO4 1.3, Na2HPO4
1.25, CaCl2 2.6, NaHCO3 22, glucose 10) bubbled with 95% O2 and
5% CO2 and maintained continuously at 35 C (Zhu et al., 2000; Okada
et al., 2003). EC layers II, III, and IV were stimulated by three electrodes
simultaneously at 5 s intervals. The stimulation intensity was adjusted to
obtain a submaximal evoked field potential (100  A). Each stimulus con-
sisted of bipolar constant current pulses of 100  sec duration. Stimulation
patterns were designed using data acquisition software (Panasonic: MED
conductor) and delivered through an isolator (BSI-2; Alpha MED Sciences
Co.). These procedures of electrical stimulation were controlled using a
computer running on Windows NT.
Online supplemental material
Fig. S1 depicts localization of synaptic vesicle proteins in the hippocam-
pus of wild-type and  3B
 /  Neo mice. Video 1 shows spontaneous sei-
zure of  3B
 /  Neo mice. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200405032/DC1.
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